Heparin cofactor activity measured with an amidolytic method.
D000208:Acute Disease; D000510:Alpha-Globulins / Q000032:analysis*; D000990:Antithrombin III / Q000009:adverse effects / Q000032:analysis* / Q000494:pharmacology; D000991:Antithrombins / Q000032:analysis / Q000172:deficiency; D001681:Biological Assay; D001780:Blood Coagulation Tests; D004211:Disseminated Intravascular Coagulation / Q000209:etiology; D005337:Fibrin / Q000032:analysis; D005340:Fibrinogen / Q000032:analysis; D006493:Heparin / Q000494:pharmacology; D006583:Hexadimethrine Bromide / Q000378:metabolism; D006801:Humans; D008103:Liver Cirrhosis / Q000209:etiology; D008722:Methods; D009203:Myocardial Infarction / Q000209:etiology; D013053:Spectrophotometry; D013917:Thrombin / Q000378:metabolism
D000510:Alpha-Globulins; D000991:Antithrombins; D006583:Hexadimethrine Bromide; D000990:Antithrombin III; D005337:Fibrin; D005340:Fibrinogen; D006493:Heparin; D013917:Thrombin